Abstract
“Bioreductive drugs” exhibit selective toxicity towards hypoxic cells, a property of potential use in cancer therapy due to the presence of hypoxic regions in solid tumours. The model for the action of these drugs involves metabolic reduction, with some species produced by that reduction being biologically active. The selectivity arises since high concentrations of oxygen inhibit reduction, the one electron reduction product transferring its extra electron O2 and reverting back to parent drug1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. Wardman, Curr. Topics Radiat. Res. 11:347 (1977).
P. A. Andrews, S. S. Pan and N. R. Bachur, J. Am. Chem. Soc. 108: 4158 (1986).
M. Egertson and S. J. Danishevsky, J. Am. Chem. Soc. 108: 4648 (1986)
M. Tomasz, R. Lipman, C. Chowdary, J. Pawlak, G. L. Verdine and K. Nakanishi, Science (Washington D.C.) 235:1204 (1987).
V. N. Iyer and W. Szybalski, Science (Washington D.C.) 145:55 (1964).
B. M. Hoey, J. Butler and A. J. Swallow, Biochemistry 27:2608 (1988).
M. A. Baker, E. M. Zeman, V. K. Hirst and J. M. Brown, Cancer Res. 48:5947 (1988).
K. Laderoute, P. Wardman and A. M. Rauth, Biochem. Pharmac. 37:1487 (1988).
B. Y. Storey, W. W. Sullivan and C. L. Mayer, J. Org. Chem. 29:3118 (1964).
I. R. Flockhart, P. Large, P. Troup, S. L. Malcolm and T. R. Marten, Xenobiotica 8:97 (1978).
A. J. Varghese, Anal. Biochem. 110:197 (1981).
J. L. Born and W. M. Hadley, Int. J. Radiat. Oncol. Biol. Phys. 11:1157 (1985).
M. I. Walton and P. Workman, Biochem. Pharmac. 36:887 (1987).
J. L. Born, W. M. Hadley, S. L. Anderson and J. M. Yuhas, “Radiation Sensitizers: Their Use in the Clinical Management of Cancer”, L. W. Brady, Ed., Masson Publishing, New York, (1980), pp 79–82.
B. Palcic, P. Josephy, K. Skov and L. P. Skarsgard, “Cytotoxicity of Hypoxic Cell Sensitizers” Proceedings of a Conference Sponsored by the Radiosensitizer/Radioprotector Working Group PCT/NCI, Banff, (1979), pp 16–18.
P. W. Whillans and G. F. Whitmore, Radiat. Res. 86:311 (1981).
T. Kagiya, H. Ide, S. Nishimoto, and T. Wada, Int. J. Radiat. Biol. 44: 505 (1983).
A. J. Varghese and G. F. Whitmore, Chem. Biol. Interact. 36:141 (1981).
A. J. Varghese and G. F. Whitmore, Chem. Biol. Interact. 56:269 (1985).
M. V. Middlestadt and A. M. Rauth, Int. J. Radiat. Oncol. Biol. Phys. 8, 709 (1982).
R. J. Knox, R. C. Knight and P. I. Edwards, Biochem. Pharmac. 32:2149 (1983).
E. P. Clarke, P. Wardman and K. H. Goulding, Biochem. Pharmac. 29:2684 (1980).
P. P. Josephy, B. Palcic and L. P. Skarsgard, Biochem. Pharmac. 30:849 (1980).
R. A. McClelland, J. R. Fuller, N. E. Seaman, A. M. Rauth and R. Battistella, Biochem. Pharmac. 33:303 (1984).
K. R. Laderoute, E. Eryvaic, R. A. McClelland and A. M. Rauth, Int. J. Radiat. Oncol. Biol. Phys. 12:1215 (1986).
R. A. McClelland, R. Panicucci and A. M. Rauth, J. Am. Chem. Soc. 107:1762 (1985).
R. A. McClelland, R. Panicucci and A. M. Rauth, J. Am. Chem. Soc. 109:4308 (1987).
J. L. Bolton and R. A. McClelland, J. Am. Chem. Soc. 111:8972 (1989)
J. L. Bolton, Ph.D. Thesis, University of Toronto (1988).
R. Panicucci, R. A. McClelland and A. M. Rauth, Int. J. Radiat. Oncol. Biol. Phys. 12:1227 (1986).
R. Panicucci, R. A. McClelland, Can. J. Chem. in press.
J. L. Bolton and R. A. McClelland, J. Mol. Struct. Theochem. 165:379 (1988).
See, for example, T. Sone, T. Tokudo, S. Shinkai and O. Manabe, J. Chem. Soc., Perkin Trans 2, 298 (1981).
E. J. T. Chrystal, R. L. Koch and P. Goldman, Mol. Pharmacol. 18:105 (1980).
A. J. Varghese and G. F. Whitmore, Cancer Res. 43:78 (1983).
J. A. Raleigh and S. F. Liu, Biochem. Pharmac. 32:1444 (1983):
J. A. Raleigh and S. F. Liu, Int. J. Radiat. Oncol. Biol. Phys. 10:1337 (1984).
A. R. J. Silver and S. S. McNeill, Biochem. Pharmac. 19:3537 (1985).
A. R. J. Silver and S. S. McNeill, P. O’Neill, T. C. Jenkins and I. Ahmed, Biochem. Pharmac. 35:3923 (1986).
D. C. Heimbrook and A. C. Sartorelli, Mol. Pharmac. 29:168 (1986).
A. J. Varghese and G. F. Whitmore, Radiat. Res. 97:262 (1984).
A. J. Varghese and G. F. Whitmore, Int. J. Radiat. Oncol. Biol. Phys. 10:1361 (1984).
R. L. Koch, C. Rose, T. A. Rose and P. Goldman, Biochem. Pharmacol. 31:411 (1982).
J. Matejovic and R. A. McClelland, unpublished results.
R. Panicucci, Ph.D. Thesis, University of Toronto (1987).
S. Farah and R. A. McClelland, unpublished results.
A. J. Varghese, Biochem. Biophys. Res. Commun. 112:1013 (1983).
E. Chacun, C. J. Morrow, A. A. Leon, J. L. Born and B. R. Smith, Biochem. Pharmacol. 37:363 (1988).
E. A. Bump, Y. C. Taylor and J. M. Brown, Cancer Res. 43:997 (1983).
A. J. Varghese and G. F. Whitmore, Int. J. Radiat. Oncol. Biol. Phys. 10:1341 (1984).
A. J. Varghese and G. F. Whitmore, Cancer Res. 40:2165 (1980).
G. G. Miller, J. Ngan-Lee and J. D. Chapman, Int. J. Radiat. Oncol. Biol. Phys. 8:741 (1982).
A. J. Franko, Int. J. Radiat. Oncol. Biol. Phys. 12:1195 (1986).
E. C. Miller, Cancer Res. 38:1479 (1978).
Y. Hashimoto, K. Shido and T. Okamoto, Acc. Chem. Res. 17:403 (1984).
D. B. Ludlum, R. J. Colinas, M. C. Kirk and J. R. Mehta, Carcinogenesis 9:593 (1988).
J. B. Chin, D. M. K. Sheinin and A. M. Rauth, Mutation Res. 58:1 (1978).
C. E. Voogd, J. J. Van Der Stel and J. J. A. A. Jacobs, Mutation Res. 66:207 (1980).
M. B. Noss, R. Panicucci, R. A. McClelland and A. M. Rauth, Biochem. Pharmac. 37:2585 (1988).
J. L. Bolton and R. A. McClelland, Can. J. Chem. 66:3044 (1988).
K. Harper and R. A. McClelland, unpublished results.
R. T. Mulcahy, J. J. Gipp, G. A. Ublacker, R. Panicucci and R. A. McClelland, Biochem. Pharmacol. 38:1667 (1989).
P. Wardman and R. A. McClelland, unpublished results.
M. B. Noss, R. Panicucci, R. A. McClelland and A. M. Rauth, Int. J. Radiat. Oncol. Biol. Phys. 16:1015 (1989).
L. Berube and A. M. Rauth, unpublished observations.
R. T. Mulcahy, unpublished observations.
Y. C. Taylor and A. M. Rauth, Br. J. Cancer 41:892 (1980).
A. M. Rauth, J. R. Milligan, R. Zeraperoni, R. Panicucci and R. A. McClelland, unpublished observations.
J. A. Raleigh, Y. S. Foo and F. L. Shu, Biochem. Pharmac. 30:2921 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
McClelland, R.A. (1990). Molecular Interactions and Biological Effects of the Products of Reduction of Nitroimidazoles. In: Adams, G.E., Breccia, A., Fielden, E.M., Wardman, P. (eds) Selective Activation of Drugs by Redox Processes. NATO ASI Series, vol 198. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3768-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3768-7_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6679-9
Online ISBN: 978-1-4615-3768-7
eBook Packages: Springer Book Archive